BERLIN, Germany and SEATTLE, March 13, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a cancer molecular diagnostics company, will hold its annual press conference and analyst meeting on Monday, March 31, 2008 and present results for the fiscal year 2007. Geert Walther Nygaard, CEO and Oliver Schacht, CFO will give an overview of the operational developments as well as provide guidance for 2008. A conference call with Epigenomics’ management will be held later on the same day.
